Invention Grant
- Patent Title: Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
-
Application No.: US15887830Application Date: 2018-02-02
-
Publication No.: US10265267B2Publication Date: 2019-04-23
- Inventor: William Gerhart , Ahmet Tutuncu , Pravin Soni
- Applicant: Respivant Sciences GmbH
- Applicant Address: CH Basel
- Assignee: RESPIVANT SCIENCES GMBH
- Current Assignee: RESPIVANT SCIENCES GMBH
- Current Assignee Address: CH Basel
- Agency: Mintz, Levin, Cohn, Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61P11/00 ; A61P11/14 ; A61K31/35 ; A61P37/08 ; A61K31/352 ; A61K47/18 ; A61M11/00
Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
Public/Granted literature
- US20180193259A1 CROMOLYN COMPOSITIONS FOR TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS Public/Granted day:2018-07-12
Information query
